Psychedelics Dutch government establishes MDMA research commission The commission will be investigating the risks and benefits associated with MDMA-assisted therapy Rowan DunneMarch 31, 2023
Psychedelics Psilocybin access denied to patients despite ongoing lawsuit against Health Canada Eight patients sued the government at the end of July last year over what they believe is a violation of constitutional rights Rowan DunneMarch 24, 2023
News Lucy Scientific and Wesana Health partner to develop CBD and psilocybin-based drug 'SANA-013' is a proprietary therapy intended to treat conditions like migraines, episodic cluster headaches and MDD Rowan DunneMarch 22, 2023
Psychedelics Oklahoma assembly passes psychedelics research bill for Veteran PTSD The state's House of Representatives approved the legislation on Thursday Rowan DunneMarch 10, 2023
News Numinus expands psychedelics research operations in Arizona This will be the company's fifth research clinic in the United States Natalia Buendia CalvilloFebruary 17, 2023
Psychedelics PharmAla Biotech signs agreement to sell clinical-grade MDMA in Australia Companies are running more MDMA and psilocybin trials after the Australian drug regulation changes Natalia Buendia CalvilloFebruary 14, 2023
Psychedelics Psyched Wellness formulates first commercial Amanita muscaria extract The cartoon-like toadstool is psychoactive, has medicinal properties and lives in a symbiotic relationship with certain trees Rowan DunneFebruary 9, 2023
Psychedelics Optimi Health submits clinical trial application after developing proprietary MDMA drug The drug will be used to help establish a safe supply for patients in Canada and Australia Rowan DunneFebruary 7, 2023
Psychedelics Calgary’s ATMA launches psychedelic-assisted therapy training course for physicians The program's creation was inspired by new regulations for psychedelic-assisted therapy in Alberta Rowan DunneJanuary 27, 2023
Psychedelics New York legislators introduce bill to legalize natural psychedelics Bill A00114 would legalize adult possession and use of ibogaine, mescaline, psilocybin and psilocin Natalia Buendia CalvilloJanuary 3, 2023